Rhythm Pharmaceuticals Inc. announced the offering, issuance, and sale of 2,058,824 shares of its common stock at $85.00 per share. The underwriters exercised their option to purchase an additional 308,823 shares, bringing the total to be issued to 2,367,647 shares. The offering, expected to close on July 11, 2025, is anticipated to generate approximately $188.7 million in net proceeds for the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.